Published in Antimicrob Agents Chemother on July 01, 1978
Novel plasmid-mediated beta-lactamase in clinical isolates of Klebsiella pneumoniae more resistant to ceftazidime than to other broad-spectrum cephalosporins. Antimicrob Agents Chemother (1988) 3.59
Amoxicillin-clavulanic acid in treatment of urinary tract infection due to gram-negative bacteria resistant to penicillin. Antimicrob Agents Chemother (1981) 1.61
Antibiotic resistance in pathogenic and producing bacteria, with special reference to beta-lactam antibiotics. Microbiol Rev (1981) 1.58
Combined antibacterial activity of amoxicillin with clavulanic acid against ampicillin-resistant strains. Antimicrob Agents Chemother (1980) 1.45
Effect of clavulanic acid on the minimum inhibitory concentration of benzylpenicillin, ampicillin, carbenicillin, or cephalothin against clinical isolates resistant to beta-lactam antibiotics. Antimicrob Agents Chemother (1979) 1.19
Twenty-one years of beating beta-lactamases. Br Med J (Clin Res Ed) (1982) 0.75
Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate. Antimicrob Agents Chemother (1972) 61.10
The beta-lactamases of gram-negative bacteria and their role in resistance to beta-lactam antibiotics. J Antimicrob Chemother (1976) 18.58
Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus. Antimicrob Agents Chemother (1977) 11.58
Cefoxitin, a semisynthetic cephamycin antibiotic: resistance to beta-lactamase inactivation. Antimicrob Agents Chemother (1974) 8.84
Influence of antibiotic stability on the results of in vitro testing procedures. J Bacteriol (1964) 6.14
LABORATORY AND CLINICAL EVALUATION OF A NEW ANTIBIOTIC--CEPHALOTHIN. Ann Intern Med (1965) 2.88
NATURAL AND ACQUIRED RESISTANCE OF KLEBSIELLA-AEROBACTER TO CEPHALOTHIN AND CEPHALORIDINE. Proc Soc Exp Biol Med (1965) 2.47
Sequential hospitalwide outbreaks of resistant Serratia and Klebsiella infections. Arch Intern Med (1977) 1.84
Novel R-plasmid-mediated beta-lactamase from Klebsiella aerogenes. Antimicrob Agents Chemother (1977) 1.34
Induction of resistance in Staphylococcus aureus and Klebsiella pneumoniae by exposure to cephalothin and cefoxitin. J Infect Dis (1976) 1.00
Cefoxitin activity against multiply antibiotic-resistance Klebsiella pneumoniae in vitro. Antimicrob Agents Chemother (1977) 0.90
Diversity of beta-lactamase activity among clinical isolates of gram-negative bacilli. Am J Clin Pathol (1976) 0.84
Mortality from asthma: a new epidemic in New Zealand. Br Med J (Clin Res Ed) (1982) 6.78
Passive smoking as well as active smoking increases the risk of acute stroke. Tob Control (1999) 3.91
Guidelines for detection and management of dyslipidaemia. Scientific Committee of the National Heart Foundation of New Zealand. N Z Med J (1993) 3.18
Human influenza resulting from aerosol inhalation. Proc Soc Exp Biol Med (1966) 2.94
Cell-mediated immunity in Cryptococcosis. Cell Immunol (1974) 2.68
Metal cation requirements for phytohemagglutinin-induced transformation of human peripheral blood lymphocytes. J Immunol (1970) 2.63
Underestimation of relative weight by use of self-reported height and weight. Am J Epidemiol (1987) 2.62
Sinusitis of the maxillary antrum. N Engl J Med (1975) 2.57
The validity of Maori hospital discharge statistics for ischaemic heart disease in New Zealand. N Z Med J (1994) 2.14
Guidelines for managing raised blood pressure. BMJ (1996) 2.03
Mycoplasma pneumoniae infections in volunteers. Ann N Y Acad Sci (1967) 1.98
Adverse antibiotic effects associated with renal insufficiency. Rev Infect Dis (1990) 1.97
An outbreak of nosocomial infection due to multiply resistant Serratia marcescens: evidence of interhospital spread. J Infect Dis (1976) 1.95
Sporadic cases of Legionnaires' disease: the expanding clinical spectrum. Ann Intern Med (1979) 1.85
Sequential hospitalwide outbreaks of resistant Serratia and Klebsiella infections. Arch Intern Med (1977) 1.84
Neutralizing and hemagglutination-inhibiting activity of nasal secretions following experimental human infection with A2 influenza virus. J Immunol (1967) 1.77
Deaths from lung cancer and ischaemic heart disease due to passive smoking in New Zealand. N Z Med J (1989) 1.66
Unsuccessful treatment of staphylococcal endocarditis with cefazolin. JAMA (1977) 1.60
Prostate cancer risk and consumption of fish oils: a dietary biomarker-based case-control study. Br J Cancer (1999) 1.58
Death from asthma in Auckland: circumstances and validation of causes. N Z Med J (1984) 1.51
Non-steroidal anti-inflammatory drugs and prostate cancer progression. Int J Cancer (1998) 1.43
Variability of sequential studies of lymphocyte blastogenesis in normal adults. Clin Exp Immunol (1976) 1.40
Gram-negative bacillary endocarditis. Interpretation of the serum bactericial test. Am J Med (1975) 1.34
Analysis of case-crossover designs. Stat Med (1993) 1.33
Factors associated with active, refractory epistaxis. Arch Otolaryngol Head Neck Surg (1988) 1.33
Variation in lymphocyte reactivity to histoplasmin during the course of chronic pulmonary histoplasmosis. Am Rev Respir Dis (1973) 1.31
Ethnic difference in the relationship between acute inflammation and serum ferritin in US adult males. Epidemiol Infect (2007) 1.30
Immunologic and clinical improvement of progressive coccidioidomycosis following administration of transfer factor. Cell Immunol (1973) 1.27
Lessons from the national asthma mortality study: circumstances surrounding death. N Z Med J (1987) 1.26
Do cholinergic neurons directly innervate nasal blood vessels? Rhinology (1988) 1.25
Anaerobic septicemia after transrectal prostatic biopsy. Arch Intern Med (1978) 1.19
Patterns of immune response in chronic pulmonary histoplasmosis. J Infect Dis (1972) 1.19
Evolution of antimicrobial resistance and nosocomial infection. Lessons from the Vanderbilt experience. Am J Med (1981) 1.18
Prostate cancer and dietary carotenoids. Am J Epidemiol (2000) 1.18
Heterocyclic amine content of cooked meat and risk of prostate cancer. J Natl Cancer Inst (1999) 1.17
The separation and characterization of proteins intrinsic to nasal secretion. J Immunol (1966) 1.15
Human responses to experimental infection with influenza A/Equi 2 virus. Am J Epidemiol (1967) 1.15
Transferrin-dependent growth inhibition of yeast-phase Histoplasma capsulatum by human serum and lymph. J Infect Dis (1980) 1.14
Persistence of neutralizing antibody in adult volunteers immunized with adnovirus soluble antigens. Proc Soc Exp Biol Med (1966) 1.13
Sulfamethoxazole-trimethoprim-polymyxin therapy of serious multiply drug-resistant Serratia infections. Antimicrob Agents Chemother (1976) 1.11
Blood pressure levels and the treatment of hypertension in Auckland, 1982. N Z Med J (1983) 1.09
Timing of major events of pharyngeal swallowing. Arch Otolaryngol Head Neck Surg (1988) 1.06
Effects of alpha and beta adrenergic agonists on nasal blood flow. Ann Otol Rhinol Laryngol (1968) 1.03
Expression of a high-affinity serotonin transporter in human lymphocytes. Int J Immunopharmacol (1994) 1.03
Stimulation and section of the vidian nerve in relation to autonomic control of the nasal vasculature. Laryngoscope (1971) 1.02
Nosocomial spread of Clostridium difficile. Infect Control (1983) 1.02
The leukocyte response during viral respiratory illness in man. Ann Intern Med (1966) 1.02
Effects of chronic bronchopulmonary disease and aging on human nasal secretion IgA concentrations. J Immunol (1968) 1.02
Retroperitoneal abscess. Case report and review of the literature. Dig Dis Sci (1980) 1.01
Hospital-acquired Klebsiella bacteremia. Am J Med Sci (1972) 0.99
Effect of inflammatory mediators on nasal mucosa. Arch Otolaryngol (1977) 0.99
Antigenic analysis of echoviruses 1 and 8. J Infect Dis (1973) 0.98
Acute cryptococcal cellulitis in renal transplant recipients. South Med J (1981) 0.97
The New Zealand Blood Donors' Health Study: baseline findings of a large prospective cohort study of injury. Inj Prev (2002) 0.95
Quantitative assessment of pharyngeal bolus driving forces. Otolaryngol Head Neck Surg (1989) 0.95
Subarachnoid space of the CNS, nasal mucosa, and lymphatic system. Arch Otolaryngol (1979) 0.95
Experimental equine influenza in Chincoteague ponies. Proc Soc Exp Biol Med (1967) 0.94
The use of labeled microspheres to determine blood flow in the dog's nasal mucosa. Ann Otol Rhinol Laryngol (1972) 0.93
Immunoglobulin classes of serum neutralizing antibody formed in response to infection with human A2 influenza virus. Proc Soc Exp Biol Med (1967) 0.93
Recent trends in asthma mortality, morbidity, and management in New Zealand. J Asthma (1989) 0.93
Malignant neoplasms of the nasal cavities and paranasal sinuses: (a retrospective study). Laryngoscope (1977) 0.93
Antagonism by chloramphenicol of broad-spectrum beta-lactam antibiotics against Klebsiella pneumoniae. Antimicrob Agents Chemother (1984) 0.93
Superior activity of N-formimidoyl thienamycin against gentamicin-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother (1981) 0.93
Multiple-attack efficacy and tolerability of sumatriptan nasal spray in the treatment of migraine. Arch Fam Med (1998) 0.92
Actinomycosis. Surgical aspects. Am Surg (1985) 0.91
Diminished immune response in sun-damaged skin. Arch Dermatol (1980) 0.91
Tranformation of lymphocytes of normal and hospitalized adults by Candida albicans extract. Proc Soc Exp Biol Med (1973) 0.91
Changing face of treatment of peritonsillar abscess. Laryngoscope (1982) 0.90
Cefoxitin activity against multiply antibiotic-resistance Klebsiella pneumoniae in vitro. Antimicrob Agents Chemother (1977) 0.90
Progressive disseminated histoplasmosis; favorable response to ketoconazole. Ann Intern Med (1981) 0.90
Accuracy of self-measurement of waist and hip circumference in men and women. J Am Diet Assoc (1997) 0.90
Effect of bile salts on nasal permeability in vitro. J Pharm Sci (1987) 0.89
Pharmacological responsiveness of the nasal mucosa. Ann Otol Rhinol Laryngol (1970) 0.88
Apparent cure of intracranial Nocardia asteroides infection by minocycline. Arch Intern Med (1979) 0.88
A case-crossover analysis of a case-control study of alcohol consumption and coronary events: the effects of exposure definition and the use of control data. J Epidemiol Biostat (2000) 0.88
Changes in the patency of the upper nasal passage induced by histamine and antihistamines. Laryngoscope (1970) 0.88
Tularemia treated successfully with gentamicin. Am Rev Respir Dis (1972) 0.87
Ontogeny of human cell-mediated immunity: age-related variation of in vitro infantile lymphocyte transformation. Infect Immun (1976) 0.87
Clinical application of the manofluorogram. Laryngoscope (1988) 0.86
Action of inflammatory mediators on middle ear mucosa. A method for measuring permeability and swelling. Arch Otolaryngol (1976) 0.86
Bacteremia and bacteriuria after transrectal prostatic biopsy. Urology (1981) 0.86
A population-based study of clinical and pathological prognostic characteristics of men with familial and sporadic prostate cancer. BJU Int (1999) 0.86
Letter: Trimethoprim-sulfamethoxazole and brain abscess. Ann Intern Med (1975) 0.86
Gentamicin-resistant bacillary infection. Clinical features and amikacin therapy. Arch Intern Med (1978) 0.86
Clostridium septicum arthritis. South Med J (1983) 0.86
Histoplasma capsulatum endocarditis cured by amphotericin B combined with surgery. Chest (1980) 0.86
Legionnaires' disease associated with massive pericardial effusion. Arch Intern Med (1981) 0.86
Candida albicans infection of sternum and costal cartilages: combined operative treatment and drug therapy and 5-fluorocytosine. Ann Thorac Surg (1977) 0.85
Evidence of alpha 2-adrenoceptors in the nasal blood vessels of the dog. Arch Otolaryngol (1984) 0.85
Conditions associated with relapse of amphotericin B-treated disseminated histoplasmosis. Johns Hopkins Med J (1982) 0.85
Prostaglandins and nasal blood flow. Ann Otol Rhinol Laryngol (1967) 0.85
Calcium, calcium blockers, and nasal smooth muscle. Arch Otolaryngol (1983) 0.84
Tinnitus due to idiopathic stapedial muscle spasm. Ear Nose Throat J (1983) 0.84
Autonomic stimulation, osmolarity and prostaglandin effects in the Eustachian tube. Ann Otol Rhinol Laryngol (1976) 0.84